C1orf194 Inhibitors belong to a specific class of chemical compounds designed to target and modulate the activity of a particular protein known as C1orf194. This protein, also referred to as Chromosome 1 Open Reading Frame 194, is a relatively lesser-known protein whose exact function and role in cellular processes remain the subject of ongoing research. C1orf194 Inhibitors are synthetic molecules that have been developed with the primary objective of interfering with the normal function or activity of C1orf194 within cells. These inhibitors are designed to bind to C1orf194, which may alter its conformation or interactions with other molecules, consequently leading to downstream effects on cellular processes in which C1orf194 is involved.
The development and study of C1orf194 Inhibitors are part of a broader effort within the field of molecular biology and drug discovery to better understand the functions of lesser-characterized proteins in the human genome. By specifically targeting C1orf194, researchers aim to elucidate its biological significance and potential roles in cellular pathways. While the precise implications of inhibiting C1orf194 are still under investigation, these inhibitors serve as valuable tools for researchers seeking to probe the protein's function and assess its potential. Further research into C1orf194 Inhibitors may provide insights into their impact on cellular processes and open up new avenues for understanding the broader molecular mechanisms in which this protein participates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Potential to reduce CFAP276 expression via cAMP pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
May inhibit CFAP276 through mTOR signaling suppression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Potential to downregulate CFAP276 via AMPK activation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
May decrease CFAP276 expression through NRF2 pathway. | ||||||
Reserpine | 50-55-5 | sc-203370 sc-203370A | 1 g 5 g | $134.00 $406.00 | 1 | |
Could potentially inhibit CFAP276 via dopamine pathway. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
May disrupt CFAP276 expression by blocking SERCA pumps. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Potential to inhibit CFAP276 through PKC pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
May inhibit CFAP276 via PI3K/Akt signaling disruption. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Could potentially downregulate CFAP276 through ERα. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
May reduce CFAP276 expression by suppressing inflammation. | ||||||